Association of 7q22..1 gene VGF with obesity & leanness
Association of 7q22..1 gene VGF with obesity & leanness
批准号:
6930016
负责人:
JOHN A MARTIGNETTI
金额:
$24.66万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-03-01 至 2009-02-28
关键词:
biotechnologybody weightelectroporationfamily geneticsfunctional /structural genomicsgene expressiongene mutationgenetic susceptibilityhereditary hyperglycemic obesityhuman datainterdisciplinary collaborationlaboratory mouselinkage mappingmicroarray technologypolymerase chain reactionregulatory genesingle nucleotide polymorphismtissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Complex neural circuits and a large number of peptide hormones and neuropeptides control feeding and energy expenditure. The VGF (non-acronymic) gene encodes a highly conserved mammalian polypeptide that is differentially cleaved in a tissue-specific manner and secreted from endocrine, neuroendocrine and neuronal cells. We have shown that targeted deletion of VGF results in profound alterations in the regulation of feeding and energy balance; VGF mutant mice are lean, hyperactive, hypermetabolic and highly resistant to obesity and diabetes. Interestingly, a number of independent genetic linkage studies have consistently shown strong evidence of a subregion linked with obesity over the VGF locus on 7q22.1 but the causative gene has not been identified. Based on its consistent linkage in independent studies and strong biological candidacy, we hypothesize that VGF is an excellent candidate gene for human obesity and leanness, and propose to investigate this using combined clinical and basic science approaches. One of us (JAM) will perform genetic association studies using a high density panel of single nucleotide polymorphisms (SNPs) in the Quebec Family Study (QFS) patient cohort who represents well-characterized samples from 950 individuals and 223 families. Several nonsynonymous, protein-altering SNPs are already known and additional SNPs across the VGF locus will be developed and fully characterized as potential functional variants and/or biomarkers. These SNPs and haplotype blocks will then be validated in a second, independent cohort of 1,425 individuals. Concurrent biologic studies (SRJS) will investigate the function of select human VGF SNPs in mouse models using gene 'knockout' and 'knock-in' strategies, and in various in vitro cell culture models where VGF expression, processing, and regulated release can be quantified. Since targeted VGF deletion generates mice that are lean and resistant to diet-induced and some forms of genetically-induced obesity, tissues from these mice, including adipose and muscle, will be used to identify additional gene products by high-density gene expression array analysis. These physiologically linked, target-tissue genes may themselves play a functional role in obesity resistance or susceptibility, and thus become excellent candidates for future investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10411413
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:9980812
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10672982
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10475624
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10469185
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10524135
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy
-
批准号:10227030
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2019
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Role of the tumor suppressor KLF6 in prostate cancer
-
批准号:7439162
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2007
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Role of the tumor suppressor KLF6 in prostate cancer
-
批准号:7798240
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2007
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Role of the tumor suppressor KLF6 in prostate cancer
-
批准号:7262066
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2007
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Role of the tumor suppressor KLF6 in prostate cancer
-
批准号:8051725
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2007
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Role of the tumor suppressor KLF6 in prostate cancer
-
批准号:7585736
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2007
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Association of 7q22..1 gene VGF with obesity & leanness
-
批准号:7216239
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2005
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Association of 7q22..1 gene VGF with obesity & leanness
-
批准号:7021395
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2005
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
Association of 7q22..1 gene VGF with obesity & leanness
-
批准号:7369886
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2005
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
GENETIC DISSECTION OF A BONE DYSPLASIA/CANCER SYNDROME
-
批准号:6181957
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1998
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
POSITIONAL CLONING OF THE GENE FOR HEREDITARY BONE DYSPLASIA
-
批准号:6115139
-
项目类别:
-
资助金额:$6.88万
-
财政年份:1998
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
GENETIC DISSECTION OF A BONE DYSPLASIA/CANCER SYNDROME
-
批准号:6387345
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1998
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
GENETIC DISSECTION OF A BONE DYSPLASIA/CANCER SYNDROME
-
批准号:6520606
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1998
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
GENETIC DISSECTION OF A BONE DYSPLASIA/CANCER SYNDROME
-
批准号:2888734
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1998
-
负责人:JOHN A MARTIGNETTI
-
依托单位:
海外基金